3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
9
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Oropharyngeal Neoplasms
7
Mouth Neoplasms
7
Laryngeal Neoplasms
7
Carcinoma
6
Hypopharyngeal Neoplasms
5
Urinary Bladder Neoplasms
4
Pancreatic Neoplasms
3
Nasopharyngeal Carcinoma
3
Vulvar Neoplasms
2
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Paranasal Sinus Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Cholangiocarcinoma
2
Anus Neoplasms
2
Adenocarcinoma of Lung
2
Urethral Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Sinonasal undifferentiated carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Sertoli-Leydig Cell Tumor
1
Interventions
Fluorouracil
6
Cisplatin
4
Radiotherapy, Intensity-Modulated
3
Radiotherapy
3
Magnetic Resonance Spectroscopy
3
Capecitabine
3
dehydroftorafur
2
Specimen Handling
2
Mitomycin
2
Cetuximab
2
toripalimab
1
rocakinogene sifuplasmid
1
pembrolizumab
1
durvalumab
1
atezolizumab
1
Vaccines
1
VGX-3100
1
Taxes
1
Radiosurgery
1
Radiation
1
Platinum
1
Paclitaxel
1
Nivolumab
1
Mitozytrex
1
Mitomycins
1
MEDI0457
1
Ipilimumab
1
Immunoglobulin G
1
Fluorodeoxyglucose F18
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Anal Canal Carcinoma
×
1,2-diaminocyclohexaneplatinum II citrate
×
Clear all
NCT02560298
2023-06-22
InterAACT
Eastern Cooperative Oncology Group
Phase 2
Unknown
91 enrolled